Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

ICL Selling Unit To Investment Firm

by Alexander H. Tullo
June 1, 2015 | A version of this story appeared in Volume 93, Issue 22

Israel Chemicals Ltd. will sell its pharmaceutical, cosmetics, and gypsum business to the private equity firm One Rock Capital Partners for an undisclosed sum. The Germany-based ICL business makes active ingredients for antacids and antiperspirants and products for dental applications. The sale, ICL says, will help it focus on agriculture, food, and engineered materials. In March, One Rock invested in the organophosphonates maker Compass Chemical.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.